Skip to main content

Table 5 Postoperative adverse effects

From: The analgesic effect of total intravenous anaesthesia with propofol versus inhalational anaesthesia for acute postoperative pain after hepatectomy: a randomized controlled trial

 

TIVA (n = 45)

SEVO (n = 45)

P-value (FDR)

Postoperative Day 1

 Nausea

10 (22.2%)

15 (33.3%)

0.239

 Vomiting

1 (2.2%)

1 (2.2%)

1

 Dizziness

5 (11.1%)

4 (8.9%)

1

 Pruritus / Itchiness

6 (13.3%)

4 (8.9%)

0.502

 Wound infection

2 (4.4%)

0 (0%)

0.494

 Urinary retention

7 (15.6%)

9 (20.5%)

0.547

 Confusion

0 (0%)

0 (0%)

–-

 Constipation

22 (48.9%)

25 (56.8%)

0.454

 Presence of adverse effects (Postoperative Day 1)

32 (71.1%)

36 (81.8%)

0.234

Postoperative Day 2

 Nausea

3 (6.7%)

12 (26.7%)

*0.011 (0.044)

 Vomiting

0 (0%)

2 (4.4%)

0.494

 Dizziness

3 (6.7%)

1 (2.2%)

0.616

 Pruritus / Itchiness

6 (13.3%)

5 (11.1%)

0.748

 Wound infection

1 (2.4%)

0 (0%)

1

 Urinary retention

2 (4.8%)

4 (10.5%)

0.416

 Confusion

0 (0%)

0 (0%)

–-

 Constipation

16 (38.1%)

25 (65.8%)

*0.013 (0.035)

 Presence of adverse effects (Postoperative Day 2)

23 (54.8%)

33 (82.5%)

*0.007 (0.056)

Postoperative Day 3

 Nausea

3 (7%)

11 (27.5%)

*0.013 (0.091)

 Vomiting

0 (0%)

2 (5%)

0.229

 Dizziness

3 (7%)

0 (0%)

0.242

 Pruritus / Itchiness

5 (11.6%)

3 (7.5%)

0.714

 Wound infection

0 (0%)

0 (0%)

–-

 Urinary retention

1 (2.4%)

5 (12.8%)

0.101

 Confusion

0 (0%)

0 (0%)

–-

 Constipation

12 (28.6%)

19 (48.7%)

0.062

 Presence of adverse effects (Postoperative Day 3)

18 (42.9%)

26 (66.7%)

0.032 (> 0.1)

  1. *p < 0.05 and FDR < 0.1, indicating the significant difference; data were analyzed by Chi-square test or Fisher’s exact test; values in N (%)